Skip to main content
Equibles

STATE STREET CORP

Position in BTAIQ — BioXcel Therapeutics, Inc.

CIK 93751 BOSTON, MA
Back to BTAIQ Full portfolio

Position in BTAIQ

as of Jun 30, 2026 · filed Sep 22, 2026
Position Value
$129,886
+$6,448 QoQ
Shares Held
92,118
0.0% QoQ
Ownership
0.294%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 47 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 68% Shared 0% None 32%

Common Shares in BTAIQ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $7,768,261,189 across 51 Drug Manufacturers - Specialty & Generic names. BTAIQ ranks #45 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 19,667,723 $1,413,322,574
2 UTHR
UNITED THERAPEUTICS Corp
 1,898,064 $1,028,428,017
3 VTRS
Viatris Inc
 53,069,461 $842,743,040
4 NBIX
Neurocrine Biosciences Inc
 4,385,598 $739,148,686
5 TEVA
Teva Pharmaceutical Industries Ltd
 18,936,548 $641,570,246
6 ALKS
Alkermes plc.
 9,160,575 $480,014,130
7 ELAN
Elanco Animal Health Inc
 16,063,046 $395,311,562
8 HIMS
Hims & Hers Health, Inc.
 8,145,699 $282,411,384

All Filings in BTAIQ

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $123,438 92,118
2025-12-31 $101,148 63,218
2025-09-30 $134,958 52,718
2024-12-31 — 77,149
2024-09-30 — 77,149
2024-06-30 — 124,749
2024-03-31 — 464,908
2023-12-31 — 440,332
2023-09-30 — 409,858
2023-06-30 — 2,072,199
2023-03-31 — 1,760,683
2022-12-31 — 368,569
2022-09-30 — 369,672
2022-06-30 — 365,256
2022-03-31 — 1,400,753
2021-12-31 — 1,345,096
2021-09-30 — 1,328,599
2021-06-30 — 1,459,115
2021-03-31 — 1,275,906
2020-12-31 — 1,673,996
2020-09-30 — 1,293,856
2020-06-30 — 974,381
2020-03-31 — 126,190